Rolf L. Andersen
Rolf L. Andersen publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #1,865,767 of 7,710,434 ranked researchers
- Rank in United States
- #571,144 of 1,627,098
- Works
- 28
- Citations
- 690
- Citations per work
- 24.6
What does Rolf L. Andersen research?
Rolf L. Andersen's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1658.9%
- Medicine1658.9%
- Everything else830.1%
- Life Sciences25.5%
- Social Sciences25.5%
- 1Surgery36% of their works
- 2Endocrinology, Diabetes and Metabolism15% of their works
- 3Economics and Econometrics6% of their works
- 4Cancer Research6% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Cardiology and Cardiovascular Medicine4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Systems, Economic Evaluations, Quality of Life
- Cancer, Lipids, and Metabolism
- Cholesterol and Lipid Metabolism
- Lipid metabolism and disorders
- Venous Thromboembolism Diagnosis and Management
- Genetic factors in colorectal cancer
Which keywords describe Rolf L. Andersen's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Atherosclerosis, Metabolic Syndrome, Cardiovascular Disease and Diabetes.
- Venous Thromboembolism
- Microsatellite Instability
- Antithrombotic Therapy
- Metabolism
- LXR
- Quality of Life
- Diabetes
- Metabolic Syndrome
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Cardiovascular Disease
- Cost-effectiveness Analysis
- Fatty Acid Synthase
- Lipid Metabolism
- ANGPTL3
- Lipoprotein Lipase
- Molecular Characterization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Statins232 topics
- Cardiovascular Disease Prevention201 topic
- Cholesterol-lowering201 topic
- Cholesterol153 topics
- Atherosclerosis143 topics
- Metabolic Syndrome112 topics
- Cardiovascular Disease91 topic
- Diabetes91 topic
- Cost-effectiveness Analysis41 topic
- Quality of Life41 topic
- Fatty Acid Synthase31 topic
- LXR31 topic
- Lipid Metabolism31 topic
- Metabolism31 topic
- ANGPTL321 topic
- Antithrombotic Therapy21 topic
- Lipoprotein Lipase21 topic
- Microsatellite Instability21 topic
- Molecular Characterization21 topic
- Venous Thromboembolism21 topic
Where does Rolf L. Andersen work?
Rolf L. Andersen's main affiliation in the publication record is Lancaster General Hospital, United States.
How many publications and citations does Rolf L. Andersen have?
OpenAlex counts 28 works and 690 citations for Rolf L. Andersen, an h-index of 9, ranking #1,865,767 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rolf L. Andersen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.